Radeco
MyClyns E-mail

myclyns 
ooo
  TO ORDER MyClyns: 
Call 860-823-1220 and ask for Part Number MYC-6ML 
Or Send Purchase Order for MYC-6ML to: 
509 Norwich Avenue Taftville, CT  06380 
Call for volume discounts! 
iii
myclyns MyClyns™ liquid spray (MYC-6ML) is the only non-alcohol first response protection you can spray directly on your face and into your eyes, ears, mouth, and nose.  MyClyns™ is a disposable one-time use product that you can keep in your pocket and spray on an affected part of your body once a suspected pathogenic exposure has occurred. MyClyns™ is designed to provide you a first line of defense in the field before you can follow your post-exposure protocols. Standard clean-up protocols should be followed when you have an opportunity to use them.

How does MyClyns™ work?
MyClyns™ contains the revolutionary Microcyn® Technology, a pH-neutral, non-irritating solution of compounds that are similar to the chemicals produced by the human body (neutrophils) in its defense against microorganisms.

These oxychlorine compounds move through the pathogen's cells and deactivate essential enzymes and structures, rendering them non-viable.

MyClyns™ has been shown to have germ-killing action against a wide range of microorganisms. Microbial populations of forty-seven (47) organisms were reduced by more than 5.0 log 10 in as little as fifteen (15) seconds of exposure to the product.

Who should use MyClyns™?

Persons who have been exposed to bodily fluids and potentially harmful microogranisms should use MyClyns™. Police Officers, EMTs, Correctional Officers, Fire Fighters, Nurses, Physicians, Phlebotomists, Lab Personnel, and Military Personnel have among the highest exposure rates of any profession.


Independent laboratory tests show that the solution in MyClyns™ demonstrates a 99.99% reduction in HIV-1, Hepatitis C, MRSA, and many other pathogens.

Image

Image 

Benefits of using MyClyns™ 


  • Versatile
  • Convenient
  • Readily Accessible
  • Safe to use on mucous and non-mucous
  • Non-Flammable
  • Non-alcohol
  • Non-irritating
  • Non-aerosol
  • Non-sensitizing

MyClynsTM Product Information 


  • Shelf life of 24 months
  • Expiration date is printed on bottom of each unit
  • Product is meant for single use only
  • Avoid extreme temperatures when storing, especially freezing.

 

Independent Laboratory Tests

Conducted At BioScience Laboratories, Inc. Bozeman, MT

On The Solution In

MyClyns™

 

Virus:

The solution in MyClyns has shown virucidal activity in in-vitro and clinical (human) in-vivo testing:

 Virus  Study Type
Performance
 Human Hepatitis C (BVDV surrogate)  clinical >99.99% reduction within 30 seconds
 Human Immunodeficiency (HIV-1/Mn) in-vitro

>93.94% reduction within 30 seconds

>99.99% reduction within 2.5 minutes

 Human Influenza A H1N1 (ATCC #VR-1520)  in-vitro
>99.99% reduction within 30 seconds
 Avian Influenza H3N2A/turkey/OH/31053/04 (AI CAD Program, University of Maryland)  in-vitro
>99.99% reduction within 30 seconds
 Herpes Simplex type 1 (HSV-1)  in-vitro
>68.74% reduction within 30 seconds

Bacteria:

The solution in MyClyns was tested using the standard OTC clinical (human) monograph test: Healthcare Personnel Handwash (HCPHW) using Serratia marcescens. The solution showed immediate efficacy after one application (>99% bacterial reduction) and met the firstreduction criteria for the HCPHW test.

Furthermore, the solution in MyClyns showed >99.99% in-vitro reduction in the following germs in as little as 15 seconds:


 Acinetobacter baumannii (ATCC #19003)
 Acinetobacter baumannii (Clinical Isolate: BSLI #061901Ab3)
 BSLI #061901Pm2)Bacteroides fragilis (ATCC #43858)
 Bacteroides fragilis (Clinical Isolate: BSLI #061901Bf6)
 Candida albicans (ATCC #10231)
 Candida albicans (Clinical Isolate: BSLI #042905Ca)
 Clostridium difficile C-diff (ATCC #9689)
 Enterobacter aerogenes (ATCC #29007)
 Enterobacter aeruginosa (Clinical Isolate: BSLI #042905Ea)
 Enterococcus faecalis (ATCC #29212)
 Enterococcus faecalis (Clinical Isolate: BSLI #061901Efs2)
 Enterococcus faecium VRE, MDR (ATCC #51559)
 Enterococcus faecium (Clinical Isolate: BSLI #061901Efm1)
 Escherichia coli (ATCC #11229)
 Escherichia coli (Clinical Isolate: BSLI #042905Ec1)
 Escherichia coli (Clinical Isolate: BSLI #042905Ec2)
 Escherichia coli (ATCC #25922)
 Haemophilus influenzae (ATCC #8149)
 Haemophilus influenzae (Clinical Isolate: BSLI #072605Hi)
 Klebsiella oxytoca MDR (ATCC #15764)
 Klebsiella oxytoca (Clinical Isolate: BSLI #061901Ko1)
 Klebsiella pneumoniae subsp. ozaenae (ATCC #29019)
 Klebsiella pneumoniae (Clinical Isolate: BSLI #061901Kpn2)
 Micrococcus luteus (ATCC #7468)
 Micrococcus luteus (Clinical Isolate: BSLI #061901M12)
 Neisseria gonorrhoeae (ATCC #19424)
 Neisseria meningitidis (ATCC #13102)
 Proteus mirabilis (ATCC #7002)
 Proteus mirabilis (Clinical Isolate: BSLI #061901Pm2)
 Pseudomonas aeruginosa (ATCC #15442) 
 Pseudomonas aeruginosa (Clinical Isolate: BSLI #072605Pa) 
 Pseudomonas aeruginosa (ATCC #27853) 
 Pseudomonas aeruginosa (Clinical Isolate: BSLI #061901Pa2) 
 Serratia marcescens (ATCC #14756)
 Serratia marcescens (Clinical Isolate: BSLI #042905Sm) 
 Staphylococcus aureus aureus (ATCC #6538) 
 Staphylococcus aureus MRSA (ATCC #700698) 
 Staphylococcus aureus VRSA (BSLI #062707NARSAVRSal)
 Staphylococcus aureus (Clinical Isolate: BSLI #061901Sa1)
 Staphylococcus aureus (ATCC #29213)
 Staphylococcus aureus (Clinical Isolate: BSLI #061901Sa2)
 Staphylococcus epidermidis (ATCC #12228)
 Staphylococcus epidermidis (Clinical Isolate: BSLI #072605Se)
 Staphylococcus haemolyticus (ATCC #29970)
 Staphylococcus haemolyticus (Clinical Isolate: BSLI #042905Sha)
 Staphylococcus hominis (ATCC #27844)
 Staphylococcus hominis (Clinical Isolate: BSLI #042905Sho)
 Staphylococcus saprophyticus (ATCC #35552)
 Staphylococcus saprophyticus (Clinical Isolate: BSLI #042905Ss)
 Streptococcus pneumoniae (ATCC #33400)
 Streptococcus pneumoniae (Clinical Isolate: BSLI #072605Spn1)
 Streptococcus pyogenes (ATCC #19615)
 Streptococcus pyogenes (Clinical Isolate: BSLI #061901Spy7)

VRE = Vancomycin-Resistant Enterococcus
MDR = Multi-Drug Resistant

Mycobacteria:

The solution in MyClyns has shown tuberculocidal (TB) activity having demonstrated a >99.9%in-vitro reduction against Mycobacterium bovis in 60 seconds.

 
Thursday, 20 November 2008
News and Events
Interview and Ad in the Fall 2007 addition of CBRNE World.

Image

Read the article written in this magazine!

Read more
RADView Dosimeter on NBC Heroes
 
heroessmall
 
NBC’s new hit show Heroes may be fictitious but the dosimeter badges the FBI are wearing on the show are not.
Read more
Coverage in the New London Day
 
radviewpic.jpg

RADēCO was interviewed by the New London Day newspaper. Click read more to read the full article.
Read more

  Image
 
  To learn more about RADView badge click the picture!
RadView
Search